Protein phosphatase 1b in the solitary tract nucleus is necessary for normal baroreflex function

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 5, 2012, Pages 472-478

  Arnold, Amy C ^a   Nautiyal, Manisha ^a   Diz, Debra I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

baroreflex sensitivity; phosphatase; solitary tract nucleus; transgenic rats

Indexed keywords

CHLORALOSE; NITROPRUSSIDE SODIUM; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; URETHAN;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LOCALIZATION; GENE EXPRESSION; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; MOLECULAR MECHANICS; NONHUMAN; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOLITARY TRACT NUCLEUS; TACHYCARDIA;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; BRADYCARDIA; HEART RATE; MALE; PHENYLEPHRINE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RATS; RATS, SPRAGUE-DAWLEY; SOLITARY NUCLEUS; TACHYCARDIA; TIME FACTORS;

EID: 84861041963     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31824ba490     Document Type: Article

References (38)

1. Soulsby M, Bennett AM. Physiological signaling specificity by protein tyrosine phosphatases. Physiology (Bethesda). 2009;24:281-289.
2. Elchebly M, Payette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283:1544-1548.
3. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, et al. PTP1B regulates leptin signal transduction in vivo. Dev Cell. 2002;2:489-495.
4. Zabolotny JM, Kim YB, Welsh LA, et al. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem. 2008;283:14230- 14241.
5. Picardi PK, Calegari VC, Prada PO, et al. Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats. Endocrinology. 2008;149:3870-3880.
6. Morrison CD, White CL, Wang Z, et al. Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Endocrinology. 2007;148:433-440.
7. Belin de Chantemele EJ, Muta K, Mintz J, et al. Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function. Circulation. 2009;120:753-763.
8. Hall JE, Brands MW, Hildebrandt DA, et al. Role of sympathetic nervous system and neuropeptides in obesity hypertension. Braz J Med Biol Res. 2000;33:605-618.
9. Arnold AC, Shaltout HA, Gallagher PE, et al. Leptin impairs cardiovagal baroreflex function at the level of the solitary tract nucleus. Hypertension. 2009;54:1001-1008.
10. Campagnole-Santos MJ, Diz DI, Ferrario CM. Baroreceptor reflex modulation by angiotensin II at the nucleus tractus solitarii. Hypertension. 1988;11(2 pt 2):I167-I171.
11. Thayer JF, Lane RD. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol. 2007;74:224-242.
12. La Rovere MT, Pinna GD, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol. 2008;13:191-207.
13. Wiesmann C, Barr KJ, Kung J, et al. Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol. 2004;11:730-737.
14. Xie L, Lee SY, Andersen JN, et al. Cellular effects of small molecule PTP1B inhibitors on insulin signaling. Biochemistry. 2003;42:12792-12804.
15. Sakima A, Averill DB, Gallagher PE, et al. Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii. Hypertension. 2005;46:333-340.
16. Arnold AC, Isa K, Shaltout HA, et al. Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus. Am J Physiol Heart Circ Physiol. 2010;299:H763-H771.
17. Parati G, Di RM, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens. 2000;18:7-19.
18. Korner PI. Cardiac baroreflex in hypertension: role of the heart and angiotensin II. Clin Exp Hypertens. 1995;17:425-439.
19. Fow JE, Averill DB, Barnes KL. Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus. Am J Physiol. 1994;267(1 pt 2):H259-H266.
20. Arnold AC, Sakima A, Ganten D, et al. Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen. Hypertension. 2008;51:1326-1331.
21. Lee H, Xie L, Luo Y, et al. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate. Biochemistry. 2006;45:234-240.
22. Lund IK, Hansen JA, Andersen HS, et al. Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J Mol Endocrinol. 2005;34:339-351.
23. Liang F, Lee SY, Liang J, et al. The role of protein-tyrosine phosphatase 1B in integrin signaling. J Biol Chem. 2005;280:24857-24863.
24. Brown-Shimer S, Johnson KA, Lawrence JB, et al. Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci U S A. 1990;87:5148-5152.
25. Menon J, Soto-Pantoja DR, Callahan MF, et al. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 2007;67:2809-2815.
26. Soto-Pantoja DR, Menon J, Gallagher PE, et al. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther. 2009;8:1676-1683.
27. Diz DI, Garcia-Espinosa MA, Gallagher PE, et al. Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2) 27 transgenic rats. J Cardiovasc Pharmacol. 2008;51:542-548.
28. Oliveira DR, Santos RA, Santos GF, et al. Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. Hypertension. 1996;27:1284-1290.
29. Grassi G, Cattaneo BM, Seravalle G, et al. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31:68-72.
30. Arnold AC, Shaltout HA, Gilliam-Davis S, et al. Autonomic control of the heart is altered in Sprague-Dawley rats with spontaneous hydronephrosis. Am J Physiol Heart Circ Physiol. 2011;300:H2206-H2213.
31. Casadei B, Paterson DJ. Should we still use nitrovasodilators to test baroreflex sensitivity? J Hypertens. 2000;18:3-6.
32. Paton JF. Convergence properties of solitary tract neurones driven synaptically by cardiac vagal afferents in the mouse. J Physiol. 1998;508(pt 1):237-252.
33. Diz DI, Jessup JA, Westwood BM, et al. Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla. Clin Exp Pharmacol Physiol. 2002;29:473-482.
34. Campagnole-Santos MJ, Diz DI, Santos RA, et al. Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol. 1989;257(1 pt 2):H324-H329.
35. Logan EM, Aileru AA, Shaltout HA, et al. The functional role of PI3K in maintenance of blood pressure and baroreflex suppression in (mRen2) 27 and mRen2. Lewis Rat. J Cardiovasc Pharmacol. 2011;58:367-373.
36. Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: cardiovascular system. Experientia. 1986;42:292-297.
37. Michelini LC, Bonagamba LG. Angiotensin II as a modulator of baroreceptor reflexes in the brainstem of conscious rats. Hypertension. 1990;15(2 suppl):I45-I50.
38. Diz DI, Arnold AC, Nautiyal M, et al. Angiotensin peptides and central autonomic regulation. Curr Opin Pharmacol. 2011;11:131-137.